|
GERN
|
Geron Corporation
|
US
|
NASDAQ
|
|
INAB
|
IN8bio, Inc.
|
US
|
NASDAQ
|
|
INKT
|
MiNK Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IPSC
|
Century Therapeutics, Inc.
|
US
|
NASDAQ
|
|
JSPR
|
Jasper Therapeutics, Inc
|
US
|
NASDAQ
|
|
LCTX
|
Lineage Cell Therapeutics, Inc.
|
US
|
AMEX
|
|
LGVN
|
Longeveron Inc.
|
US
|
NASDAQ
|
|
LSTA
|
Lisata Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LYEL
|
Lyell Immunopharma, Inc.
|
US
|
NASDAQ
|
|
MESO
|
Mesoblast Limited
|
US
|
NASDAQ
|
|
MGTA
|
Magenta Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NRBO
|
NeuroBo Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
NUVA
|
NuVasive, Inc.
|
US
|
NASDAQ
|
|
NVIV
|
InVivo Therapeutics Holdings Corp.
|
US
|
NASDAQ
|
|
OCX
|
OncoCyte Corporation
|
US
|
NASDAQ
|
|
ORGS
|
Orgenesis Inc.
|
US
|
NASDAQ
|
|
PGEN
|
Precigen, Inc.
|
US
|
NASDAQ
|
|
PLUR
|
Pluri Inc.
|
US
|
NASDAQ
|
|
PTE
|
PolarityTE, Inc.
|
US
|
NASDAQ
|
|
SNTI
|
Senti Biosciences, Inc.
|
US
|
NASDAQ
|